Related Experiment Video
Updated: Jul 14, 2026
10:30
A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
Long-term effects of botulinum toxin on neuromuscular function
Christiane G Frick1, Martina Richtsfeld, Nita D Sahani
1Department of Anesthesia and Critical Care, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA. christiane_frick@web.de
Anesthesiology
|May 26, 2007
Summary
Botulinum toxin causes long-term muscle atrophy and increased nicotinic acetylcholine receptors (nAChRs) in a dose-dependent manner. These neuromuscular changes affect muscle relaxant interactions, with up-regulated nAChRs potentially compensating for denervation effects.
Area of Science:
- Neuroscience
- Pharmacology
- Muscle Physiology
Background:
- Clostridium botulinum infections are increasing, particularly in drug abusers and tissue allograft recipients.
- Botulinum toxin's potential use in biochemical warfare necessitates understanding its effects.
- Neurotoxin-induced paralysis often requires mechanical ventilation and muscle relaxants.
Purpose of the Study:
- To investigate long-term effects of botulinum toxin on muscle function.
- To evaluate changes in nicotinic acetylcholine receptors (nAChRs) expression.
- To assess the interaction between botulinum toxin and the muscle relaxant atracurium.
Main Methods:
- Rats were injected with varying doses of botulinum toxin in the tibialis muscle.
- Control groups received saline injections.
- Neuromuscular function, atracurium pharmacodynamics, and nAChR concentrations were evaluated at 128 days post-injection.
Main Results:
- Botulinum toxin decreased nerve-evoked tensions and muscle mass dose-dependently.
- Specific muscle tension remained unchanged, indicating muscle atrophy as the cause of tension loss.
- Nicotinic acetylcholine receptor (nAChR) concentrations significantly increased in a dose-dependent manner.
Conclusions:
- Botulinum toxin induces long-term, dose-dependent neuromuscular changes primarily through muscle atrophy.
- Altered responses to atracurium suggest interactions with varying nAChR isoforms.
- Up-regulated nAChRs may compensate for botulinum toxin-induced denervation, preventing neuromuscular fade.
Related Concept Videos
01:22Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
01:29Neuromuscular Junction And Blockade
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...